Camelia Chiriac
About Camelia Chiriac
Camelia Chiriac is a Principal Scientist at Bristol-Myers Squibb with over 25 years of experience in the pharmaceutical and biotechnology industries, specializing in drug discovery and development.
Title and Current Role
Camelia Chiriac currently holds the position of Principal Scientist at Bristol-Myers Squibb. She oversees critical projects in drug discovery and development, leveraging her extensive experience in the pharmaceutical and biotechnology sectors. Her role involves leading cross-functional teams and contributing to the overall scientific direction of the company.
Professional Background
Camelia Chiriac has had a significant career spanning over 25 years. Before her current role as Principal Scientist, she worked at Bristol-Myers Squibb in various capacities, including Senior Scientist from 2018 to 2022, Scientist from 2016 to 2018, and Research Scientist from 2009 to 2012. She also served as a Research Associate at Venenum BioDesign, LLC from 2012 to 2016 and held positions at Princeton University and Wyeth. Her career is marked by diverse roles in leading research and development projects.
Education and Expertise
Camelia Chiriac achieved her M.Sc. from The University of British Columbia and her B.Sc. from the University of Waterloo. Her educational background laid a solid foundation for her specialization in drug discovery and development, molecular biology, and biochemistry. She has extensive expertise in these areas, which she has successfully applied in her various roles within the pharmaceutical industry.
Industry Contributions
Throughout her career, Camelia Chiriac has contributed to multiple successful drug development projects. She has a proven track record of publishing research in peer-reviewed journals and has been involved in mentoring junior scientists and researchers. Her collaborations with academic institutions and industry partners have further enhanced her contributions to the field of drug discovery.